SCHEMBL457757

SCHEMBL457757

Brc1[c]cc(-c2ccccc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.50
MAPK1 P28482 2/20 0.50
TAAR1 Q96RJ0 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
HSD17B10 Q99714 1/20 0.39
MMP3 P08254 1/20 0.39
BCL2L1 Q07817 1/20 0.39
CRHBP P24387 1/20 0.37
CRHR2 Q13324 1/20 0.37
NPC1 O15118 1/20 0.36
NFKB1 P19838 1/20 0.36
RAB9A P51151 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
MGLL Q99685 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5584368 0.87
SCHEMBL15063634 0.83 ALDH1A1 (0.46) ALDH1A1MAPK1NPC1NFKB1RAB9A
SCHEMBL15063736 0.79 BCL2L1 (0.35) CYP1A2CYP3A4BCL2L1NPC1RAB9A
SCHEMBL15063844 0.79 ALDH1A1 (0.40) ALDH1A1TDP1HSD17B10NPC1RAB9A
SCHEMBL15063814 0.79 CYP1A2 (0.42) ALDH1A1CYP1A2NPC1RAB9ASMN1; SMN2
SCHEMBL15063561 0.79
SCHEMBL15063620 0.79 RAB9A (0.41) ALDH1A1MAPK1CYP1A2HSD17B10NPC1
SCHEMBL15064041 0.76 ALDH1A1 (0.52) ALDH1A1MAPK1TDP1HSD17B10NPC1
SCHEMBL15064180 0.76 TAAR1 (0.48) TAAR1CYP3A4RELAPTPN1NOTUM
SCHEMBL15063939 0.76 ESR2 (0.47) TAAR1ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102408380-B 5-aminopyrimidine-thione compounds and preparation method thereof UNIV ZHEJIANG 2014-04-16 CN claimed
CN-102408380-A 5-aminopyrimidine thioketone compound and preparation method thereof UNIV ZHEJIANG 2012-04-11 CN claimed
EP-3045450-B1 INTERMEDIATE COMPOUNDS IN PROCESSES FOR PRODUCING PYRIDAZINONE COMPOUNDS SUMITOMO CHEMICAL CO (JP) 2018-02-07 EP disclosed
EP-3045450-A1 INTERMEDIATE COMPOUNDS IN A PROCESS FOR PRODUCING PYRIDAZINONE COMPOUNDS SUMITOMO CHEMICAL CO., LTD. (JP) 2016-07-20 EP disclosed
EP-2614053-B1 METHOD FOR PRODUCING PYRIDAZINONE COMPOUNDS AND INTERMEDIATES THEREOF SUMITOMO CHEMICAL CO (JP) 2016-03-23 EP disclosed
US-9040709-B2 Method for producing pyridazinone compounds and intermediate thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-05-26 US disclosed
US-20140378688-A1 METHOD FOR PRODUCING PYRIDAZINONE COMPOUNDS AND INTERMEDIATE THEREOF SUMITOMO CHEMICAL CO (JP) 2014-12-25 US disclosed
US-8884010-B2 Method for producing pyridazinone compounds and intermediate thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-11-11 US disclosed
CN-102408380-B 5-aminopyrimidine-thione compounds and preparation method thereof UNIV ZHEJIANG 2014-04-16 CN disclosed
CN-102260131-B Method for mirror selective addition of alkenones NAT UNIV TSING HUA 2013-11-06 CN disclosed
EP-2614053-A1 METHOD FOR PRODUCING PYRIDAZINONE COMPOUNDS AND INTERMEDIATE THEREOF SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2013-07-17 EP disclosed
US-20130172556-A1 METHOD FOR PRODUCING PYRIDAZINONE COMPOUNDS AND INTERMEDIATE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-07-04 US disclosed
CN-102408380-A 5-aminopyrimidine thioketone compound and preparation method thereof UNIV ZHEJIANG 2012-04-11 CN disclosed
WO-2012033225-A1 METHOD FOR PRODUCING PYRIDAZINONE COMPOUNDS AND INTERMEDIATE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-03-15 WO disclosed
CN-102260131-A Method for mirror selective addition of alkenones 2011-11-30 CN disclosed
CN-100391943-C Prepn. of 3-position substituted indole derivative UNIV ZHEJIANG (CN) 2008-06-04 CN disclosed
CN-1834089-A Prepn. of 3-position substituted indole derivative UNIV ZHEJIANG (CN) 2006-09-20 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130172556-A1 METHOD FOR PRODUCING PYRIDAZINONE COMPOUNDS AND INTERMEDIATE THEREOF PDXK, DHPS, NQO1 ALDH1A1 482/4885MAPK1 3269/4885TAAR1 2943/4885
US-20140378688-A1 METHOD FOR PRODUCING PYRIDAZINONE COMPOUNDS AND INTERMEDIATE THEREOF PDXK, DHPS, NQO1 ALDH1A1 482/4885MAPK1 3269/4885TAAR1 2943/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.